Peptide Glossary: 50+ Terms Explained for Beginners and Researchers

Peptide research comes with a dense vocabulary that can make even straightforward concepts difficult to understand. Whether you're reading a clinical study, evaluating a protocol, or trying to understand what your provider is recommending, this glossary covers the terms you'll encounter most often — defined in plain language without sacrificing accuracy.

Terms are grouped by category for easier navigation.

Peptide Chemistry Fundamentals

Amino acid: The basic building block of proteins and peptides. There are 20 standard amino acids used in the human body, each with a unique side chain that determines its chemical behavior. Peptides are chains of amino acids linked together.

Peptide: A short chain of amino acids linked by peptide bonds, typically fewer than 50 amino acids. Larger chains are called proteins. The cutoff is somewhat arbitrary — some sources set it at 50, others at 100 amino acids.

Dipeptide, tripeptide, tetrapeptide: Chains of 2, 3, and 4 amino acids, respectively. GHK (copper peptide) is a tripeptide. Epithalon is a tetrapeptide. BPC-157 is a pentadecapeptide (15 amino acids).

Peptide bond: The covalent chemical bond that links the carboxyl group of one amino acid to the amino group of the next. This bond gives peptide chains their linear structure.

Primary structure: The sequence of amino acids in a peptide chain. The specific order determines the peptide's shape, function, and biological activity.

Conformation: The three-dimensional shape a peptide adopts. Many peptides must fold into specific conformations to bind their target receptors effectively.

Lyophilization (freeze-drying): The process of removing water from a peptide solution by freezing it and then reducing pressure to allow the frozen water to sublimate directly to vapor. Lyophilized peptides are powders that store more stably than solutions and must be reconstituted before use.

Reconstitution: The process of dissolving a lyophilized (freeze-dried) peptide powder in a liquid (typically bacteriostatic water) to create an injectable solution. The volume of liquid used determines the concentration.

Bacteriostatic water (BW): Sterile water containing 0.9% benzyl alcohol, which prevents bacterial growth. The standard diluent for reconstituting peptides for injection. It allows the reconstituted solution to be stored for up to 28–30 days when refrigerated.

Sterile water: Water that contains no microorganisms but no preservative. Should be used immediately after reconstitution (no multi-dose use) or with peptides where benzyl alcohol is incompatible.

Concentration: The amount of peptide dissolved per unit volume of solution, typically expressed as mcg/mL or mg/mL. Correct concentration calculation is essential for accurate dosing.

Half-life: The time required for the concentration of a substance in the body to reduce by half. A peptide with a 2-hour half-life will have 50% of its original concentration remaining after 2 hours, 25% after 4 hours, etc.

Receptor and Mechanism Terms

Receptor: A protein on the surface of (or inside) a cell that binds a specific molecule and triggers a cellular response. Peptides work by binding to specific receptors.

Agonist: A molecule that binds to a receptor and activates it, producing a biological response. Most therapeutic peptides are agonists — they mimic or enhance the action of natural signaling molecules.

Antagonist: A molecule that binds to a receptor but blocks its activation. Some therapeutic peptides are antagonists (e.g., GnRH antagonists used in fertility medicine).

Partial agonist: A molecule that binds and activates a receptor but produces a smaller maximum response than a full agonist. PT-141 acts as a partial agonist at some melanocortin receptors.

Downregulation: A decrease in the number or sensitivity of receptors in response to prolonged stimulation. Relevant when considering whether continuous peptide use will produce diminishing returns over time.

Selectivity: The degree to which a peptide affects one receptor or tissue type versus others. Ipamorelin's high selectivity for GH release (vs. cortisol or prolactin) is one of its key advantages.

Bioavailability: The fraction of an administered substance that reaches systemic circulation in active form. Oral peptides typically have very low bioavailability due to digestion. Injectable peptides have near-100% bioavailability. Intranasal peptides vary.

Growth Hormone Axis Terms

GHRH (Growth Hormone Releasing Hormone): A peptide produced in the hypothalamus that stimulates the pituitary gland to release growth hormone. Sermorelin and CJC-1295 are synthetic GHRH analogs.

GHRP (Growth Hormone Releasing Peptide): A class of synthetic peptides that stimulate GH release through a different receptor than GHRH (the ghrelin receptor, or GHS-R1a). Ipamorelin, GHRP-6, and GHRP-2 are GHRPs.

GHS-R1a (Growth Hormone Secretagogue Receptor 1a): The receptor that ghrelin and GHRPs bind to, triggering GH release from the pituitary.

Secretagogue: Any substance that causes another substance to be secreted. GH secretagogues (both GHRHs and GHRPs) stimulate GH release from the pituitary.

IGF-1 (Insulin-like Growth Factor 1): A hormone produced primarily in the liver in response to GH stimulation. IGF-1 mediates many of GH's anabolic and repair effects. It is the primary lab marker used to assess GH axis activity.

DAC (Drug Affinity Complex): A chemical modification added to CJC-1295 that allows it to bind to albumin in the blood, dramatically extending its half-life from minutes to days. CJC-1295 without DAC (also called Mod GRF 1-29) has a shorter half-life similar to natural GHRH.

Pulsatile release: The natural pattern of GH secretion, which occurs in pulses (primarily during deep sleep) rather than continuously. GHRP protocols aim to mimic this physiologic pattern.

Somatostatin: A hormone that inhibits GH release. It is the body's natural counterbalance to GHRH. The GH peptide window — the period of reduced somatostatin tone — is why timing injections at bedtime can maximize GH release.

Peptide Modification Terms

Analog: A compound structurally similar to a naturally occurring molecule but modified to alter its properties (half-life, potency, selectivity). Most therapeutic peptides are analogs of natural peptides.

PEGylation: The attachment of polyethylene glycol (PEG) chains to a peptide. PEGylation typically increases half-life, reduces immune response, and improves stability. Widely used in pharmaceutical peptide development.

Acetylation: Addition of an acetyl group to a peptide, often at the N-terminus. Can affect stability, receptor binding, and half-life.

Amidation: Modification of the C-terminus of a peptide to an amide group. Many natural signaling peptides are C-terminally amidated; this modification often increases potency and stability.

Cyclization: Formation of a circular peptide structure by linking the ends. Cyclic peptides are typically more stable and resistant to enzymatic degradation than linear forms.

Truncation: Shortening a peptide by removing amino acids from one or both ends. TB-500 is a truncated fragment of the larger Thymosin Beta-4 protein.

Administration Terms

Subcutaneous (SQ) injection: Injection into the subcutaneous fat layer just beneath the skin. The most common route for peptide injections. Sites include abdomen, thigh, and upper arm.

Intramuscular (IM) injection: Injection directly into muscle tissue. Less commonly used for peptides but appropriate for some compounds and protocols.

Intranasal: Administration via the nasal mucosa, where peptides can bypass the blood-brain barrier and reach the central nervous system more effectively. Used for oxytocin, PT-141, and some experimental neuropeptides.

Subcutaneous bioavailability: The fraction of a subcutaneously injected peptide that reaches systemic circulation. Generally 90–100% for most peptides.

Injection site rotation: Changing the injection location with each dose to prevent lipohypertrophy (thickening of subcutaneous tissue) at frequently injected sites.

Peptide Classes by Function

GLP-1 receptor agonist: Peptides that mimic glucagon-like peptide-1, a gut hormone that regulates insulin secretion and appetite. Semaglutide and tirzepatide belong to this class.

Melanocortin receptor agonist: Peptides that activate melanocortin receptors in the brain and periphery, affecting skin pigmentation, appetite, sexual function, and inflammation. PT-141 and Melanotan II are melanocortin agonists.

GnRH (Gonadotropin-releasing hormone): A hypothalamic hormone that controls reproductive hormone release. GnRH analogs (leuprolide, triptorelin) are used in hormone-sensitive cancers and fertility treatments.

Thymic peptides: Peptides derived from the thymus gland involved in immune system regulation. Thymosin Alpha-1 and Thymosin Beta-4 (TB-500) are thymic peptides.

Copper peptides: Peptides that bind and carry copper ions, using copper's catalytic properties to drive tissue repair and collagen synthesis. GHK-Cu is the primary example.

Research and Safety Terms

LD50: The dose of a substance required to kill 50% of a test population. BPC-157 is notable for having no established LD50 in animal studies, indicating very low acute toxicity.

Certificate of Analysis (COA): A document from a testing laboratory certifying the purity, identity, and quality of a peptide. Third-party COAs are the minimum quality verification standard for research peptides.

GMP (Good Manufacturing Practice): Quality standards applied to pharmaceutical manufacturing. Pharmaceutical-grade peptides are produced under GMP conditions; research peptides may not be.

Off-label use: Use of an approved drug for an indication not listed in its FDA approval. Sermorelin prescribed to adults (approved only for children) is an example of off-label peptide use.

Endotoxin: Bacterial cell wall components that can contaminate improperly manufactured peptides and cause fever, inflammation, and in severe cases, sepsis. Third-party testing for endotoxin contamination is a critical quality check.

Frequently Asked Questions

Q: What is the difference between a peptide and a protein? Size is the primary distinction, though the cutoff is not universally defined. Peptides are typically chains of fewer than 50–100 amino acids; proteins are longer. Functionally, peptides tend to be smaller signaling molecules while proteins form larger structural and enzymatic components. Insulin (51 amino acids) sits near this boundary and is often called both.

Q: What does "mcg" mean on a peptide label? Micrograms. One microgram equals one-thousandth of a milligram, or one-millionth of a gram. Most peptides are dosed in micrograms (100–500 mcg) rather than milligrams because they are biologically active at very small amounts.

Q: Why is reconstitution important to get right? Incorrect reconstitution volume leads to incorrect dosing. If you reconstitute a 5mg vial in 1mL of bacteriostatic water, you get a 5mg/mL (5000 mcg/mL) solution. Drawing 0.1mL gives 500 mcg. If you accidentally add 2mL, the same draw gives 250 mcg — half the intended dose. Accurate reconstitution and dose calculation are fundamental to protocol success.

Q: What is a "loading dose" in peptide protocols? An initial higher dose (or more frequent dosing) intended to rapidly build tissue levels before transitioning to a lower maintenance dose. TB-500 is commonly used with a loading phase (higher weekly doses for 4–6 weeks) followed by a lower maintenance dose. See strongest peptides for healing for specific protocol examples.

Q: Where can I learn more about specific peptides mentioned in this glossary? This site has in-depth guides on the top 10 peptides in 2026, most researched peptides, safest peptides to use, and fastest acting peptides.